We are live on
!
Find out more
WCM
Weld Capital Management Portfolio holdings
AUM
$98.8M
1-Year Est. Return
52.83%
This Fund
S&P 500
This Quarter
Est. Return
+31.95%
1 Year Est. Return
+52.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$58.8M
(+30%)
Cap. Flow
+$27.3M
Cap. Flow
% of AUM
10.69%
Top 10 Holdings %
Top 10 Hldgs %
8.39%
Holding
719
New
321
Increased
57
Reduced
70
Closed
271
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.86M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$2.35M |
| 3 |
Voya Financial
VOYA
|
+$2.1M |
| 4 |
Idacorp
IDA
|
+$2.03M |
| 5 |
Cardinal Health
CAH
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$2.11M |
| 2 |
VER
VEREIT, Inc.
VER
|
+$1.99M |
| 3 |
Lam Research
LRCX
|
+$1.92M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.84M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.35% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Technology | 12.47% |
| 4 | Financials | 12.13% |
| 5 | Industrials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
West Pharmaceutical
WST
$23.7B
| $1.19M | 0.46% |
+5,215
| New | +$1.02M |
|
52
Nutanix
NTNX
$16.1B
| $1.18M | 0.46% |
+49,761
| New | +$1.03M |
|
53
Wingstop
WING
$3.8B
| $1.17M | 0.46% |
8,439
-1,173
| -12% | -$137K |
|
54
Grand Canyon Education
LOPE
$4.22B
| $1.17M | 0.46% |
+12,878
| New | +$1.15M |
|
55
Evercore
EVR
$11.8B
| $1.15M | 0.45% |
19,581
+3,827
| +24% | +$208K |
|
56
Equity Lifestyle Properties
ELS
$13.1B
| $1.14M | 0.45% |
18,198
-17,330
| -49% | -$1.06M |
|
57
MKS Inc
MKSI
$17.4B
| $1.11M | 0.44% |
9,798
-2,840
| -22% | -$283K |
|
58
Idexx Laboratories
IDXX
$44.9B
| $1.1M | 0.43% |
+3,343
| New | +$968K |
|
59
Globus Medical
GMED
$11.1B
| $1.09M | 0.43% |
+22,955
| New | +$1.11M |
|
|
GLIBA
60
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $1.08M | 0.42% |
+15,201
| New | +$974K |
|
|
HOLX
61
DELISTED
Hologic
HOLX
| $1.08M | 0.42% |
+18,879
| New | +$926K |
|
62
Insmed
INSM
$22.4B
| $1.07M | 0.42% |
+38,839
| New | +$921K |
|
|
VAR
63
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.07M | 0.42% |
+8,734
| New | +$1.01M |
|
64
Sociedad Química y Minera de Chile
SQM
$19.3B
| $1.06M | 0.41% |
+40,579
| New | +$975K |
|
65
APA Corp
APA
$13B
| $1.05M | 0.41% |
77,535
+33,346
| +75% | +$380K |
|
|
IAA
66
DELISTED
IAA, Inc. Common Stock
IAA
| $1.05M | 0.41% |
+27,118
| New | +$1.01M |
|
|
SWCH
67
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.04M | 0.41% |
58,390
+46,481
| +390% | +$814K |
|
68
AXIS Capital
AXS
$7.73B
| $1.04M | 0.41% |
25,582
+14,462
| +130% | +$557K |
|
69
Capri Holdings
CPRI
$1.82B
| $1.04M | 0.41% |
+66,397
| New | +$983K |
|
70
Petrobras
PBR
$120B
| $1.02M | 0.4% |
123,291
+34,972
| +40% | +$253K |
|
|
SBNY
71
DELISTED
Signature Bank
SBNY
| $1.02M | 0.4% |
9,501
+4,296
| +83% | +$423K |
|
72
Kimberly-Clark
KMB
$37.6B
| $1.01M | 0.4% |
+7,140
| New | +$986K |
|
|
AVYA
73
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.01M | 0.39% |
+81,408
| New | +$938K |
|
|
GTLS
74
DELISTED
Chart Industries
GTLS
| $997K | 0.39% |
20,564
+12,313
| +149% | +$451K |
|
75
Crocs
CROX
$6.63B
| $992K | 0.39% |
+26,934
| New | +$713K |
|
Similar funds
BCM
CCM
RGM
RC
TCM
AC
QVT
WFWM
Weld Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Weld Capital Management held 719 positions worth $255M, up 30% from $196M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Weld Capital Management deployed $27.3M of net new capital in Q2 2020, opening 321 new positions and adding to 57 existing holdings. Its largest new stake was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Lam Research, an estimated $1.92M trimmed.
- Weld Capital Management's largest Q2 2020 buy was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
- Weld Capital Management added most to GoDaddy in Q2 2020, an estimated $1.61M increase.
- Weld Capital Management's biggest Q2 2020 reduction was Lam Research, cutting an estimated $1.92M.
- Weld Capital Management fully exited Vertex Pharmaceuticals in Q2 2020, selling an estimated $2.11M.
- Weld Capital Management's ten largest holdings make up 8.4% of its $255M portfolio in Q2 2020.
- Weld Capital Management opened 321 new positions and closed 271 in Q2 2020.
- Weld Capital Management's portfolio value rose 30% quarter-over-quarter to $255M.
Based on Weld Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.